mle 12 (ATCC)
Structured Review

Mle 12, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1054 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mle 12/product/ATCC
Average 97 stars, based on 1054 article reviews
Images
1) Product Images from "IFITM1 is required for epithelial mesenchymal transition in airway remodeling of allergic asthma ☆ "
Article Title: IFITM1 is required for epithelial mesenchymal transition in airway remodeling of allergic asthma
Journal: The World Allergy Organization Journal
doi: 10.1016/j.waojou.2026.101339
Figure Legend Snippet: IFN-β increases IFITM1 in airway epithelial cells. (A) RT‒qPCR analysis of IFN-ɑ expression in lung tissues (n = 5/group). (B) RT‒qPCR analysis of IFN-β expression in lung tissues (n = 5/group). (C) ELISA analysis of IFN-β expression in lung tissues (n = 6/group). (D) IFN-β in murine lung tissues costained with DAPI (blue), E-cad (green) and IFN-β (red); original magnification, 200×; scale bar, 100 μm; original magnification, 800×; scale bar, 25 μm. (E) Plasma levels of IFN-β in the control group (n = 19) and asthma group (n = 27). (F) Western blot analysis of IFITM1 expression in BEAS-2B cells treated with different concentrations of IFN-β extract. (G) Western blot analysis of IFITM1 expression in MLE-12 cells treated with different concentrations of IFN-β extract. (H) Western blot analysis of p-STAT1/STAT1 expression in BEAS-2B cells treated with IFN-β extract (1 ng/mL). (I) Western blot analysis of p-STAT1/STAT1 expression in MLE-12 cells treated with IFN-β extract (1 ng/mL). (J) Western blot analysis of p-STAT1/STAT1 and IFITM1 expression in BEAS-2B cells treated with human IFN-β extract (1 ng/mL) with or without fludarabine (1 μM) for 24 h. (K) Western blot analysis of p-STAT1/STAT1 and IFITM1 expression in MLE-12 cells treated with mouse IFN-β extract (1 ng/mL) with or without fludarabine (1 μM) for 24 h. The values are presented as the mean ± SD. The results were obtained from at least 3 independent tests. ∗ P < 0.05, ∗∗ P < 0.01.
Techniques Used: Expressing, Enzyme-linked Immunosorbent Assay, Clinical Proteomics, Control, Western Blot


